intracranial hemorrhage associated with Aptivus (tipranavir)
Health Canada is warning of intracranial hemorrhage associated with Aptivus (tipranavir).
Aptivus is given in combination with low-dose ritonavir for patients who are resistant to multiple protease inhibitors.
There are now reports that Aptivus patients have suffered intracranial hemorrhage...and some have died.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote